Mitogen-activated protein kinases in cell-cycle control

被引:0
作者
Rebecca A. MacCorkle
Tse-Hua Tan
机构
[1] Baylor College of Medicine,Department of Immunology
来源
Cell Biochemistry and Biophysics | 2005年 / 43卷
关键词
Signal transduction; MAPK; p38; ERK; JNK; cell cycle; protein kinase;
D O I
暂无
中图分类号
学科分类号
摘要
The mitogen-activated protein kinase (MAPK) family of kinases connects extracellular stimuli with diverse cellular responses ranging from activation or suppression of gene expression to the regulation of cell mortality, growth, and differentiation. The MAPK family has been studied extensively; however, the role of these kinases in cell growth and cell-cycle control has become increasingly complex. Patterns have begun to emerge from these studies that show the functions of MAPK subfamilies at different stages of the cell cycle. Their patterns of subcellular localization and movement during the cell cycle are subfamily-specific and have raised many questions about possible cell-cycle functions that have yet to be demonstrated. This article will compare and contrast our current understanding of the functions and localization patterns of the MAPK subfamilies (ERK, BMK, p38, and JNK) in cell-cycle control.
引用
收藏
页码:451 / 461
页数:10
相关论文
共 413 条
[1]  
Kyriakis J. M.(2001)Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation Physiol. Rev. 81 807-869
[2]  
Avruch J.(2003)Regulation of MAP kinase signaling modules by scaffold proteins in mammals Annu. Rev. Cell Dev. Biol. 19 91-118
[3]  
Morrison D. K.(2001)Regulation of nuclear localization during signaling J. Biol. Chem. 276 20805-20808
[4]  
Davis R. J.(1998)Growth factor-induced p42/p44 MAPK nuclear translocation and retention requires both MAPK activation and neosynthesis of nuclear anchoring proteins J. Cell Biol. 142 625-626
[5]  
Cyert M. S.(1999)Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry EMBO J. 18 664-674
[6]  
Lenormand P.(2002)The Ras-Raf-MEK-ERK Pathway in the treatment of cancer Onkologie 25 511-518
[7]  
Brondello J.-M.(2001)Blocking oncogenic ras signaling for cancer therapy J. Natl. Cancer Inst. 93 1062-1074
[8]  
Brunet A.(1994)Cyclins and cancer II: cyclin D and cdk inhibitors come of age Cell 79 572-582
[9]  
Pouyssgeur J.(2004)MEK1 and MEK2, different regulators of the G1/S transition J. Biol. Chem. 279 43861-43869
[10]  
Brunet A.(1994)Functional divergence of the MAP kinase pathway. ERK1 and ERK2 activate specific transcription factors FEBS Lett. 346 229-234